Back to Journals » Clinical and Experimental Gastroenterology » Volume 10

Duodenal and jejunal Dieulafoy’s lesions: optimal management

Authors Yılmaz TU, Kozan R

Received 22 June 2017

Accepted for publication 4 October 2017

Published 7 November 2017 Volume 2017:10 Pages 275—283


Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Everson L.A. Artifon

Tonguç Utku Yılmaz,1 Ramazan Kozan2

1Acibadem University Atakent Hospital, Organ Transplantation Unit, Istanbul, Turkey, 2Eren Hospital, General Surgery Unit, Istanbul, Turkey

Abstract: Dieulafoy’s lesions (DLs) are rare and cause gastrointestinal bleeding resulting from erosion of dilated submucosal vessels. The most common location for DL is the stomach, followed by duodenum. There is little information about duodenal and jejunal DLs. Challenges for diagnosis and treatment of Dieulafoy’s lesions include the rare nature of the disease, asymptomatic patients, bleeding symptoms often requiring rapid diagnosis and treatment in symptomatic patients, variability in the diagnosis and treatment methods resulting from different lesion locations, and the risk of re-bleeding. For these reasons, there is no universal consensus about the diagnosis and treatment approach. There are few published case reports and case series recently published. Most duodenal DLs are not evaluated seperately in the studies, which makes it difficult to determine the optimal model. In this study, we summarize the general aspects and recent approaches used to treat duodenal DL.

Dieulafoy’s lesion, gastrointestinal bleeding, duodenum, endoscopy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]